Stocktwits on X: "Puma Biotechnology is tanking after-hours, down over -30% on the likelihood it won't get approval from European agency for its cancer drug. https://t.co/To0cg7EEgW $PBYI https://t.co/QMKqfhSV7l" / X
Puma Biotechnology (PBYI) to Report Q4 Earnings: What's in Store? - February 27, 2024 - Zacks.com
This Biotech Stock Has Soared 84% This Week On Breast-Cancer Drug News | Investor's Business Daily